Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors: European Journal of Internal Medicine

C. Campochiaro; N. Farina; A. Tomelleri; R. Ferrara; S. Viola; C. Lazzari; G. De Luca; D. Raggi; A. Bulotta; M. Matucci-Cerinic; A. Necchi; M. Garassino; V. Gregorc; L. Dagna

doi:10.1016/j.ejim.2022.07.005

Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors: European Journal of Internal Medicine

C. Campochiaro, N. Farina, A. Tomelleri, R. Ferrara, S. Viola, C. Lazzari, G. De Luca, D. Raggi, A. Bulotta, M. Matucci-Cerinic, A. Necchi, M. Garassino, V. Gregorc, L. Dagna

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	95-99
Number of pages	5
Journal	Eur. J. Intern. Med.
Volume	103
DOIs	https://doi.org/10.1016/j.ejim.2022.07.005
Publication status	Published - 2022

Access to Document

10.1016/j.ejim.2022.07.005

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133821285&doi=10.1016%2fj.ejim.2022.07.005&partnerID=40&md5=dbea3f4f3a3a46454b7babd1aaba7a34

Cite this

Campochiaro, C., Farina, N., Tomelleri, A., Ferrara, R., Viola, S., Lazzari, C., De Luca, G., Raggi, D., Bulotta, A., Matucci-Cerinic, M., Necchi, A., Garassino, M., Gregorc, V., & Dagna, L. (2022). Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors: European Journal of Internal Medicine. Eur. J. Intern. Med., 103, 95-99. https://doi.org/10.1016/j.ejim.2022.07.005

Campochiaro, C, Farina, N, Tomelleri, A, Ferrara, R, Viola, S, Lazzari, C, De Luca, G, Raggi, D, Bulotta, A, Matucci-Cerinic, M, Necchi, A , Garassino, M , Gregorc, V & Dagna, L 2022, 'Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors: European Journal of Internal Medicine', Eur. J. Intern. Med., vol. 103, pp. 95-99. https://doi.org/10.1016/j.ejim.2022.07.005

@article{b20693f34f8a4754b3046a5d7021d5f3,

title = "Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors: European Journal of Internal Medicine",

author = "C. Campochiaro and N. Farina and A. Tomelleri and R. Ferrara and S. Viola and C. Lazzari and {De Luca}, G. and D. Raggi and A. Bulotta and M. Matucci-Cerinic and A. Necchi and M. Garassino and V. Gregorc and L. Dagna",

note = "Export Date: 21 November 2022; Cited By: 0; Correspondence Address: C. Campochiaro; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan, via Olgettina 60, 20132, Italy; email: campochiaro.corrado@hsr.it; CODEN: EJIME",

year = "2022",

doi = "10.1016/j.ejim.2022.07.005",

language = "English",

volume = "103",

pages = "95--99",

journal = "Eur. J. Intern. Med.",

issn = "0953-6205",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors

T2 - European Journal of Internal Medicine

AU - Campochiaro, C.

AU - Farina, N.

AU - Tomelleri, A.

AU - Ferrara, R.

AU - Viola, S.

AU - Lazzari, C.

AU - De Luca, G.

AU - Raggi, D.

AU - Bulotta, A.

AU - Matucci-Cerinic, M.

AU - Necchi, A.

AU - Garassino, M.

AU - Gregorc, V.

AU - Dagna, L.

N1 - Export Date: 21 November 2022; Cited By: 0; Correspondence Address: C. Campochiaro; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan, via Olgettina 60, 20132, Italy; email: campochiaro.corrado@hsr.it; CODEN: EJIME

PY - 2022

Y1 - 2022

U2 - 10.1016/j.ejim.2022.07.005

DO - 10.1016/j.ejim.2022.07.005

M3 - Article

SN - 0953-6205

VL - 103

SP - 95

EP - 99

JO - Eur. J. Intern. Med.

JF - Eur. J. Intern. Med.

ER -